Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday.
Interacting with students at the India International Science Festival in Bhopal, Ella also said that the homegrown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.
"Our nasal vaccine will be officially launched on January 26, on Republic Day," Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Featured Video Of The Day
Just Triptii Dimri Slaying In Black At An Event
Bharat Biotech Adds Top Medical Body ICMR As Co-Owner Of Covid Vaccine Patent Covid Vaccinated Pregnant Women At Lower Risk Of Caesarean Births: Study Fact Check: Can Covaxin Lead To Death After 2 Years Of Vaccination? "Will Stop Singing Songs On Alcohol If...": Diljit Dosanjh Sets A Condition Gujarat MBBS Student Made To Stand For Hours During Ragging, Dies Delhi Wakes Up To Season's Worst Air Quality, Visibility Drops To 150 Metres ICSI CSEET November Result 2024 Released, Check Steps To Download Congressman-Elect Opposes Tariffs On India, Fears Trade War Top Court Fumes At Centre Over No-Show In Beant Singh Assassin Case Track Latest News Live on NDTV.com and get news updates from India and around the world.